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Abstract
Background:  It is well known that smoking and pregnancy induced hypertension (PIH) are
associated with decreased fetal growth. It has been reported that in preeclampsia the fetal growth
deficit attributable to smoking is higher, which has been contradicted in other studies. We
therefore evaluated the effects on fetal growth of early- and late onset PIH and chronic
hypertension and how cigarette smoking modify these effects. We also quantified the proportion
of small for gestational age (SGA) cases attributable to PIH, chronic hypertension, and smoking.
Methods: Population-based study based on record of 215598 singleton pregnancies from the
Medical Birth Registry of Norway.
Results: In severe preeclampsia, mild preeclampsia, transient hypertension, and normotension in
term birth, odds ratios (ORs) of SGA in smokers compared with non-smokers were 1.4 (95%
confidence interval 0.9, 2.2), 1.6 (1.3, 1.9), 2.3 (1.8, 3.1), and 2.0 (1.9, 2.1), respectively. For preterm
births, corresponding ORs were 1.3 (0.9, 2.0), 1.8 (1.1, 3.0), 4.1 (1.9, 9.0), and 1.7 (1.4, 2.0),
respectively. The effect of early onset PIH was stronger than that in term births, while the effect of
smoking was equal in preterm and term newborns. Only in non-smokers who delivered at term,
the rates of SGA significantly increased with the severity of PIH (ORs = 1.3 (1.1, 1.5), 1.8 (1.7, 2.0),
and 2.5 (2.2, 3.0) for transient hypertension, mild-, and severe preeclampsia, respectively). The
combined effects of smoking and hypertension were generally not synergistic. The effect of smoking
was not stronger in women who had chronic hypertension. Nor were the effects of chronic
hypertension stronger in smokers. PIH explained 21.9 and 2.5% of preterm and term cases of SGA,
respectively, while smoking explained 12% of SGA cases.
Conclusion: The effects of hypertensive disorder and smoking were generally not synergistic,
which suggest that they may exert their main actions on separate sites or work through separate
mechanisms within or outside the placenta. If smoking were eliminated in pregnant women, the
number of SGA cases would be reduced by 12%.
Background
The hypothesis that placental dysfunction is involved in
the development of pregnancy induced hypertension
(PIH) has been supported by numerous studies [1-3].
Thus, clinical studies have suggested that preclampsia,
especially early onset, often is preceded by placental dys-
function in terms of fetal growth restriction (FGR) [4].
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arteries in early pregnancy, which may cause occlusion of
the vessels, has been observed both in preeclampsia and
FGR [1,2]. Eventually, products released by the ischemic
placenta cause endothelial activation resulting in hyper-
tension and proteinuria as well as decreased fetal growth
[5]. Still, the pathogenesis of preeclampsia is far from clar-
ified and it has even been suggested that early and late
onset preeclampsia represent two different diseases [6,7]
It is well known that also cigarette smoking is associated
with FGR. On the other hand, many studies have reported
that smoking reduces the risk of PIH [8-10]. The effects on
fetal growth of smoking in women who have PIH and, vice
versa, of PIH in women who smoke, are unclear. Neither
is it known whether such effects are different in early and
late onset PIH. It has been reported that in preeclampsia
the fetal growth deficit attributable to smoking is higher
[9], which has been contradicted in other studies [11-13].
Furthermore, we are not aware of studies that have
explored the combined effects of smoking in the different
subgroups of hypertensive complications in pregnancy.
In the present study we wanted to evaluate and compare
the effects on fetal growth of early- and late onset PIH
(transient hypertension, mild preeclampsia, and severe
preeclampsia) as well as chronic hypertension and how
cigarette smoking modify these effects. We also wanted to
quantify the proportion of SGA cases attributable to PIH,
chronic hypertension, and smoking.
Methods
Since 1967, all births in Norway are notified to the Medi-
cal Birth Registry of Norway based on compulsory notifi-
cation [14]. More than 99% of pregnant women receive
standardized antenatal care [15]. The registry comprises
medical data on all live births and abortions at 12 weeks
gestation or more including abortions induced on medi-
cal indications. Data are transferred by the midwives to
the notification form from the pregnancy record which
the women bring to the delivery unit. Within the ninth
day post partum, the notification form is completed and
sent to the Medical Birth Registry. In 1999, a revised ver-
sion of the notification form was implemented to include
new variables like data on maternal smoking habits. Sub-
groups of hypertensive disorders in pregnancy are notified
by checking of boxes [14].
The present study was based on records of all single births
in Norway from 1999 to 2002, altogether 223541 births.
We excluded pregnancies with gestational age outside the
range 27–42 weeks of gestation (n = 5294), women with
chronic renal disease (n = 918), rheumatoid arthritis (n =
270), heart disease (n = 1146), and diabetes mellitus (n =
1235), leaving 215598 pregnancies for study. Gestational
age was based on ultrasound scanning at 17–19 weeks of
gestation. In pregnancies lacking data on ultrasound dat-
ing (3%), gestational age was based on the last menstrual
period.
Clinical criteria of PIH in Norway have been in accord-
ance with the recommendations by the American College
of Obstetricians and Gynecologists in 1972 [16], which
are also referred to in the Medical Birth Registry's instruc-
tions for completion of the notification form. Transient
hypertension implies pregnancy induced hypertension
without proteinuria with BP ≥ 140/90 (one or both values
exceeded) or rise in systolic BP ≥ 30 mmHg or diastolic BP
≥ 15 mmHg after 20 weeks of gestation. Mild preeclamp-
sia implies systolic BP 140–159, diastolic BP 90–109, rise
in systolic BP ≥ 30 mmHg, or diastolic BP ≥ 15 mmHg and
proteinuria ≥ 1+. Severe preeclampsia implies BP ≥ 160/
110 and/or proteinuria ≥ 2+.
Daily smokers and non-smokers at the beginning of preg-
nancy were followed to delivery with respect to the size of
their newborns. The two cohorts were divided into six
mutually exclusive groups: transient hypertension, mild
and severe preeclampsia, chronic hypertension without
preeclampsia, preeclampsia superimposed on chronic
hypertension, and normotensive pregnancies (Tables 1–6
[see Additional file 1] [see Additional file 2]).
Statistical analysis
To achieve normal distributions, birthweight was ln-trans-
formed. Birthweight was regressed against gestational age
using fractional polynomials [17]. In order to calculate
gender and birth order specific birthweight percentiles,
birth order (1 or 2+) and fetal gender were added to the
polynomial equation. The method of scaled absolute
residuals was used to model standard deviation (SD)
against gestational age [18]. For each observation, the
standard deviation score (z-score) was the distance in SDs
from the mean regression line. The 10th birthweight per-
centile was calculated as mean – 1.282 SD.
The associations of PIH and chronic hypertension with
SGA were estimated by odds ratios (ORs) obtained from
logistic regression analysis, in which we adjusted for
maternal age in years (19 or less, 20–29, 30–34, and 35 or
more). Effects of hypertension on birthweight and its SD
score were also assessed by analysis of variance were we
adjusted for maternal age. Birthweight deficits attributa-
ble to smoking and hypertensive disorder, as expressed as
mean reduction in SD scores of birthweight, were calcu-
lated by post hoc pairwise comparisons. To investigate
modifications of the effects on birthweight of smoking
and hypertension, we included a multiplicative interac-
tion term of smoking with each five hypertensive disor-
ders in logistic regression models. A non-significant
interaction term indicated that smoking and e.g. severeBMC Pregnancy and Childbirth 2006, 6:16 http://www.biomedcentral.com/1471-2393/6/16
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preeclampsia did not affect each other. An interaction
term in which the odds ratio (OR) was significantly below
1 was considered antagonistic, while an interaction term
in which the OR significantly exceeded 1 was considered
synergistic [19].
To estimate the proportion of all cases of SGA attributable
to hypertensive disorder and smoking, adjusted popula-
tion attributable risk fractions (PAR%) were calculated as
proportion of exposed among all cases × (RR-1)/RR,
where RR is the adjusted relative risk [20]. ORs adjusted
for smoking and maternal age were used to calculate
approximate adjusted RRs [21].
We used SPSS (Statistical Package for the Social Sciences;
SPSS, Inc, Chicago, IL) for analysis.
We confirm that research ethics committees in Norway
regularly exempt research on anonymized registry data
from ethical review.
Results
Women with chronic hypertension were older than those
who were normotensive or had PIH and women with
transient hypertension were older than those who had
preeclampsia (Table 1 [see Additional file 1]). Compared
with normotensive women, those with PIH and superim-
posed preeclampsia were more likely to be nulliparous.
However, the proportions of birth order 1 in women with
chronic hypertension without preeclampsia and normote-
sive women were not significantly different. Women who
smoked were younger than non-smokers.
Smokers had lower rates of transient hypertension and
preeclampsia than nonsmokers (Table 2 [see Additional
file 1]) with ORs between 0.7 and 0.8. However, the
occurrence of chronic hypertension was statistically non-
different in smokers and non-smokers.
Mothers with severe preeclampsia or preeclampsia super-
imposed on chronic hypertension gave birth earlier than
those who had mild preeclampsia or transient hyperten-
sion (Figure 1). Median gestational age at birth in tran-
sient hypertension, mild-, and severe preeclampsia were
279, 277, and 259 days, respectively, against 280 days in
normotensive pregnancies, while those with chronic
hypertension with and without preeclampsia had median
gestational age of 268 and 279 days, respectively. The
rates of preterm birth (less than 37 weeks of gestation) in
transient hypertension, mild-, and severe preeclampsia
were 8.1, 9.7, and 48.2%, respectively, against 5.0% in
normotensive women. The rates were also significantly
higher in chronic hypertension with or without preec-
lampsia (34.5% and 8.9%).
Birthweights were lower in smokers than in non-smokers
(Table 3 [see Additional file 1]). For term births, mean
birthweights in non-smokers consistently decreased with
severity of PIH. Thus, in transient hypertension, mild- or
severe preeclampsia mean birthweights were 3596 g, 3524
g, and 3274 g, respectively, against 3644 g for normoten-
sive women. For smokers, no such trend was found. How-
ever, irrespective of smoking status and time of delivery,
those with severe preeclampsia had lower birthweights
than those with mild preeclampsia and transient hyper-
tension, but without significant differences in smokers
who delivered preterm.
In the assessment of the smoking effect, it appeared that
in preterm and term births, smokers had consistently
higher rates of SGA (Table 4 [see Additional file 1]) and
reduction in birthweight (Table 5 [see Additional file 2]).
Infants of normotensive women who smoked were twice
as likely to be SGA (ORs 2.0 and 1.7 in term and preterm
births, respectively (Table 4 [see Additional file 1]). Con-
trary to a hypothesis that the effect of smoking on fetal
Figure 1
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growth increases with severity of PIH, the effect on SGA
rather seemed to decrease with severity (Table 4 [see Addi-
tional file 1]). Thus, in severe preeclampsia in term births,
ORs of SGA in smokers compared with non-smokers was
1.4 compared with 2.0 in normotensive smokers. For pre-
term births, corresponding ORs were 1.3 and 1.7, respec-
tively. However, neither in preterm- nor in term births, the
ORs were significantly different. Consistently, in term
births with transient hypertension, mild-, or severe preec-
lampsia, mean birthweight deficits attributable to smok-
ing were 0.40 SD scores (171 g), 0.19 SD scores (64 g),
and 0.18 SD scores (75 g), respectively (Table 5 [see Addi-
tional file 2]). For preterm births, corresponding deficits
were 0.61 SD scores (320 g), 0.40 SD scores (327 g), and
0.13 SD scores (86 g).
In the assessment of the effect of PIH it appeared that in
preterm and term births in smokers as well as non-smok-
ers, women with PIH had consistently higher rates of SGA
(Table 4 [see Additional file 1]). Women with PIH had
excess birthweight deficit (Table 5 [see Additional file 2]),
with the exception of smokers who delivered at term. In
general, the effect of PIH, as indicated by ORs of SGA
(Table 4 [see Additional file 1] and birthweight deficit
(Table 5 [see Additional file 2]), were significantly more
pronounced in those who delivered preterm than at term.
Only in non-smokers who delivered at term, rates of SGA
significantly increased with the severity of PIH (ORs = 1.3,
1.8, and 2.5 for transient hypertension, mild-, and severe
preeclampsia, respectively) (Table 4 [see Additional file
1]). Consistently, birthweight deficits also significantly
increased with the severity of PIH and were 0.03 SD scores
(48 g), 0.07 SD scores (120 g), and 0.28 SD scores (370 g)
for transient hypertension, mild-, and severe preeclamp-
sia, respectively. In smokers a weaker, if any effect of sever-
ity of PIH was noted. Nor in preterm births, the smoking
effects on SGA were significantly modified by severity of
PIH.
The effect of smoking on birthweight was not significantly
stronger in women who had chronic hypertension or
superimposed preeclampsia than in normotensive
women (Table 4 [see Additional file 1]). Nor were the
effects of chronic hypertension with and without preec-
lampsia significantly different in smokers and non-smok-
ers.
To test for significant interactions between smoking and
hypertension, we added multiplicative interaction terms
of smoking with each of the five hypertensive disorders in
the logistic regression models for term and preterm births.
In term births, the only significant interaction was mild
preeclampsia × smoking (OR compared with normoten-
sive non-smokers = 0.8; p = 0.016) and thus the actual OR
for smokers with mild preeclampsia of 2.8 (Table 4 [see
Additional file 1]) (1.8 × 2.0 × 0.8) would suggest antago-
nistic effects. In preterm births, transient hypertension ×
smoking (OR = 2.5; p = 0.024) was significant. Thus, the
actual OR of 10.9 (2.6 × 1.7 × 2.5) (Table 4 [see Addi-
tional file 1]) in smokers with transient hypertension
indicated synergistic effects.
For preterm-, term births, and the whole gestational age
period, the sums of adjusted category specific population
attributable risk fractions for SGA were 34.5, 16.6, and
17.7%, respectively (Table 6 [see Additional file 2]). Thus,
34.5% and 16.6% of all cases of SGA in the population
born preterm and at term were attributable to the com-
bined effects of PIH, chronic hypertension, smoking, and
high maternal age (35 years+). PIH explained 21.9% (2.6
+ 7.9 + 11.4) of preterm cases of SGA and 2.5% of term
cases while chronic hypertension explained 1% or less.
Smoking alone explained 9.3 and 11.9% of preterm and
term SGA cases.
Discussion
We found lower birthweights in infants of mothers who
were smoking or had a hypertensive disorder in preg-
nancy. The combined effects of smoking and hyperten-
sion on birthweight were generally not synergistic. Our
study indicates that the effect of early onset PIH was sig-
nificantly stronger than the effect of late onset, while the
effect of smoking was equal in preterm and term new-
borns. Smoking explained more than 9 and 12% of pre-
term and term cases of SGA, while hypertension explained
22% of SGA cases in preterm births and less than 2.5% in
term births.
A strength of this study was its large size and the inclusion
of data on subgroups of hypertensive disorders. Based on
data from the total Norwegian birth population, the study
was most likely not affected by selection bias. Data on
maternal smoking were collected in early pregnancy, pre-
cluding recall bias. Some of the effect of PIH on birth-
weight might be explained by shared risk factors for PIH
and FGR that were not adjusted for in the present analysis,
such as thrombophilia which have been associated with
both conditions [22], but not consistently [23]. However,
most established risk factors for PIH and FGR, such as
maternal short stature are weak or uncommon and would
not influence the associations essentially. Due to lack of
data, we were not able to include in the study excessive
weight gain and prepregnancy weight, which are both
strong and common risk factors for PIH, but tend to
increase birthweight [24]. Thus, adjusting for maternal
weight or weight gain would increase rather than decrease
the effect of PIH on birthweight.
Consistent with earlier studies [11-13] that reported no
significant interaction of smoking with PIH, the effect ofBMC Pregnancy and Childbirth 2006, 6:16 http://www.biomedcentral.com/1471-2393/6/16
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smoking in the present study was not more pronounced
in those who also had PIH. Although not significant, the
effect of smoking in women with PIH even seemed to
decrease with severity of PIH. Thus, the combination of
preterm transient hypertension and smoking significantly
exceeded the expected effect under a multiplicative model
(Table 4). A Swedish study [9] reported much higher
smoking-attributable fetal growth deficit in smokers who
developed preeclampsia, which was consistent with a syn-
ergistic effect. The reason for the conflicting results with
the Swedish study is obscure. In that study, SGA was
defined as birthweight less than 2 SDs below the birth-
weight mean for gestational age, which corresponds to
about the 2.5th percentile, while we defined SGA as birth-
weight below the 10th percentile (1.282 SD below the
study population's mean curve for gestational age). How-
ever, this can hardly explain the discrepancy.
Few studies have compared the effects of smoking in
infants born preterm and at term. In the present study,
nomotensive smokers were twice more likely than normo-
tensive non-smokers to deliver an SGA infant to term as
well as preterm, which agrees with a Swedish study [25].
We are not aware of studies that have compared the effects
of smoking in early and late onset subgroups of PIH. As in
normotensive pregnancies, we found statistically equal
effects of smoking in preterm- and term transient hyper-
tension, mild-, and severe preeclampsia.
Our finding, that PIH was associated with decreased fetal
growth, agrees with earlier studies [7,9,11,13]. Cnattin-
gius et al. [9] reported increasing effect on fetal growth
with severity of PIH both in smokers and non-smokers. In
the present study, the effect of PIH increased significantly
with severity of PIH only in non-smokers with late onset
PIH. The effect of early onset PIH on fetal growth was sig-
nificantly more pronounced than PIH in women who
delivered to term, which is consistent with earlier studies
that even report excess of large newborns in late onset PIH
[6,7].
Smoking and PIH have been reported to exert their effects
on fetal growth through different placental and vascular
mechanisms. Clinical studies have suggested that in early
onset preclampsia, FGR often precedes the development
of hypertension and proteinuria [4]. Shallow invasion by
fetal trophoblasts in maternal spiral arteries in early preg-
nancy, which may cause occlusion of the spiral arteries,
has been observed both in preeclampsia and FGR [1,2].
Adaptive changes on the fetal side such as increased capil-
lary diameter and proliferation of the trophoblastic villi
have been considered secondary to the maternal vascular
lesions [26]. In contrast to these adaptive changes,
decreased fetal capillary diameter and no evidence of tro-
phoblast proliferation have been found in smokers [27].
Eventually, products released by the ischemic placenta
cause maternal endothelial activation which leads to
preeclampsia [28,29]. Also this secondary endothelial
activation involves several mechanisms that may affect
fetal growth [29-32]. It is well known that smoking also
leads to endothelial alterations. However, in pregnant
women smoking has been associated with reduced mark-
ers of endothelial activation such as cellular fibronectin
and vascular cell adhesion molecule-1, which is consistent
with the reduced incidence of PIH in smokers [33,34].
In the present study, the effects of hypertensive disorder
and smoking were generally not synergistic, which sug-
gests that they may exert their main actions on separate
sites or work through separate mechanisms within or out-
side the placenta [19]. Still, some of these pathways seem,
at least to some extent, to be shared by smoking and PIH.
However, the relative importance of each mechanism in
smoking and PIH is unknown. Among vascular mecha-
nisms are endothelial activation which likely causes
reduced production or activity of vasodilators such as
prostacyclin [30], nitric oxide [31], and increased levels of
the potent vasoconstrictors thromboxane A2 [32] and
endothelin-1 [29], thereby reducing utero-placental
blood flow and consequently fetal growth. Smokers also
have decreased nitric oxide synthetase activities in the pla-
centa [35], raised endothelin-1 activity [36,37], and raised
thomboxane to prostacyclin ratio, which may contribute
to the reduced fetal growth, although smokers have raised
prostacyclin as well as thromboxane activities [38,39].
Carbon monoxide from tobacco smoke interferes with
oxygen transfer and replaces oxygen from maternal and
fetal hemoglobin and thus reduces fetal growth [40], but
is unclear whether carbon monoxide is involved in the
effects of hypertension on fetal growth.
Of interest is that 11% of preterm SGA cases were
explained by severe preeclampsia, while chronic hyper-
tension explained 1%. In the present study, PIH explained
2.5% and 22% of all term and preterm SGA cases, respec-
tively. Our results confirm that smoking is an important
cause of FGR. Smoking, which is regarded as the most
important known preventable risk factor for FGR,
explained about 12% SGA cases which agrees with other
recent studies [41,42]. This means that the number of SGA
cases would be reduced by 12%, or about 2600 cases in
the study population, if smoking were eliminated in preg-
nant women.
Conclusion
The effects of hypertensive disorder and smoking are gen-
erally not synergistic, which suggest that they may exert
their main actions on separate sites or work through sep-
arate mechanisms within or outside the placenta. Infants
of mothers who smoke or have a hypertensive disorder inBMC Pregnancy and Childbirth 2006, 6:16 http://www.biomedcentral.com/1471-2393/6/16
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pregnancy have reduced birthweights. The effect of early
onset PIH seems to be significantly stronger than the effect
of late onset, while the effect of smoking is equal in pre-
term and term newborns. If smoking were eliminated in
pregnant women, the number of SGA cases would be
reduced by 12%, while hypertension explained 22% of
SGA cases in preterm births and less than 2.5% in term
births.
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